Europe — EMA

Paclitaxel Accord

Paclitaxel, the active ingredient in Paclitaxel Accord, is an antineoplastic presented as a injection for intravenous use. It treats various solid tumours and is used in adult oncology patients.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord, is an antineoplastic presented as a injection for intravenous use. It treats various solid tumours and is used in adult oncology patients. GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel Accord is used in the treatment of cancers that arise from epithelial cells. It is indicated for: - Breast Cancer: Improves the overall response rate in patients with metastatic disease. - Ovarian Cancer: Used as first‑line therapy in combination with carb ‑ c . - Non‑small cell Lung Cancer: Provides tumor shrink . -

What are the side effects of Paclitaxel?

Paclin … … ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →